Clinical Trials on Breast Cancer Survivors Receiving Aromatase Inhibitor Therapy in Korea, Democratic People's Republic of
Total 11 results
-
Samsung Medical CenterRecruitingTriple Negative Breast Cancer | Immune Checkpoint InhibitorKorea, Republic of
-
National Cancer Center, KoreaCompletedBreast Cancer SurvivorsKorea, Republic of
-
Seoul National University HospitalMedical Research Collaborating Center, Seoul, KoreaCompletedSexual Dysfunction | Breast Cancer SurvivorsKorea, Republic of
-
Samsung Medical CenterRecruitingBreast Cancer | Metastatic Breast Cancer | Radiation Therapy ComplicationKorea, Republic of
-
Yonsei UniversityActive, not recruitingBreast Cancer | Radiation TherapyKorea, Republic of
-
National Nutrition and Food Technology InstituteUnknownBreast Cancer SurvivorsIran, Islamic Republic of
-
National Nutrition and Food Technology InstituteUnknownBreast Cancer SurvivorsIran, Islamic Republic of
-
Isfahan University of Medical SciencesCompletedBreast Cancer SurvivorsIran, Islamic Republic of
-
Novartis PharmaceuticalsCompletedPre-menopausal Breast Cancer | PI3K Pathway InhibitionTaiwan, Hong Kong, Thailand, Korea, Republic of
-
German Breast GroupPfizer; AGO Study Group; Breast International Group; NSABP Foundation IncCompletedBreast Cancer | Hormonreceptor Positive | Her2-normal | Postneoadjuvant Treatment With CDK 4/6 Inhibitor | CPS-EG ScoreUnited States, Australia, Austria, Canada, France, Germany, Ireland, Japan, Korea, Republic of, Spain, United Kingdom
-
Taichung Veterans General HospitalRecruitingBreast Cancer | Lymphedema | Axillary Web Syndrome | Extracorporeal Shock Wave TherapyTaiwan